Molecular Insights into the Potential Anticancer Property of a Diimine-Diazo Molecule: A Molecular Docking and Molecular Dynamics Simulations Perspective

Abstract

Cancer is a disease in which cells grow abnormally and uncontrollably and destroy body tissue, and it is one of the most important threats to human health. In this study, the interaction of a molecule containing imine and azo groups (DIDA) with tumor growth-related VEGFR2 (PDB ID: 2XIR) and EGFR (PDB ID: 1M17) proteins was investigated by molecular docking and molecular dynamics simulation methods. The molecular docking study revealed that the best binding occurred between DIDA-2XIR with a binding energy of -12.4 kcal/mol. Molecular dynamics simulation was used to verify the stability of the DIDA-2XIR complex. RMSD, RMSF, SASA, Rg parameters and number of hydrogen bonds obtained during molecular dynamics simulations showed that the DIDA-2XIR complex was stable at the molecular level. Our findings have made an important contribution to the understanding of the mechanism of interaction of the DIDA with VEGFR2 and support its availability as a potential VEGFR2 inhibitor.

Keywords

• Anticancer
• molecular docking
• molecular dynamics simulation
• inhibitor

References

1. X. Liu, Z. Wang, X. Zhang, X. Lv, Y. Sun, R. Dong, G. Li, X. Ren, Z. Ji, X.A. Yuan, Z. Liu, Configurationally regulated half-sandwich iridium(III)-ferrocene heteronuclear metal complexes: Potential anticancer agents, J. Inorg. Biochem. 249 (2023) 112393.
2. A. Castellano-Hinojosa, M.J. Gallardo-Altamirano, J. González-López, A. González-Martínez, Anticancer drugs drive changes in the performance, abundance, diversity, and composition of eukaryotic communities of an aerobic granular sludge system, Chemosphere, 345 (2023) 140374.
3. K.B. Patel, S. Mukherjee, H. Bhatt, D. Rajani, I. Ahmad, H. Patel, P. Kumari, Synthesis, docking, and biological investigations of new coumarin-piperazine hybrids as potential antibacterial and anticancer agents, J. Mol. Struct., 1276 (2023) 134755.
4. I. Ali, M. Hozaifa, S. Ali, A. Malik, M. Locatelli, Advances in ionic liquids as future anti-cancer drugs, J. Mol. Liq., 388 (2023) 122823.
5. O. Iwaloye, P.O. Ottu, F. Olawale, O.O. Babalola, O.O. Elekofehinti, B. Kikiowo, A.E. Adegboyega, H.N. Ogbonna, C.F. Adeboboye, I.M. Folorunso, A.E. Fakayode, M.O. Akinjiyan, S.A. Onikanni, S. Shityakov, Computer-aided drug design in anti-cancer drug discovery: What have we learnt and what is the way forward?, Inform. Med. Unlocked., 41 (2023) 101332.
6. S.Z. Gheshlaghi, A. Ebrahimi, Z. Faghih, Z. Faghih, A. Shahraki, L. Emami, Azole-methyl-3-(4-phenoxyphenyl) quinazolin-4(3H) ones, novel quinazoline-azole hybrid scaffolds, as new potent anticancer agents: Design, synthesis, biological evaluation, molecular dynamic simulation and theoretical approach, Tetrahedron, 147 (2023) 133650.
7. B. Türkmenoğlu, Investigation of novel compounds via in silico approaches of EGFR inhibitors as anticancer agents, J. Indian Chem. Soc., 99 (2022) 100601.
8. P. Jia, J. Pei, G. Wang, X. Pan, Y. Zhu, Y. Wu, L. Ouyang, The roles of computer-aided drug synthesis in drug development, Green Synth. Catal., 3 (2022) 11–24.

9. S. Kecel-Gunduz, Y. Budama-Kilinc, B. Gok, B. Bicak, G. Akman, B. Arvas, F. Aydogan, C. Yolacan, Computer-aided anticancer drug design: In vitro and in silico studies of new iminocoumarin derivative, J. Mol. Struct., 1239 (2021) 130539.
10. I.H. Eissa, R.G. Yousef, M.A. Asmaey, H. Elkady, D.Z. Husein, A.A. Alsfouk, I.M. Ibrahim, M.A. Elkady, E.B. Elkaeed, A.M. Metwaly, Computer-assisted drug discovery (CADD) of an anti-cancer derivative of the theobromine alkaloid inhibiting VEGFR-2, Saudi Pharm. J., 31 (2023) 101852.
11. C. Mottini, F. Napolitano, Z. Li, X. Gao, L. Cardone, Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets, Semin Cancer Biol., 68 (2021) 59–74.
12. I.H. Eissa, R.G. Yousef, M. Sami, E.B. Elkaeed, B.A. Alsfouk, I.M. Ibrahim, D.Z. Husein, H. Elkady, A.M. Metwaly, Exploring the anticancer properties of a new nicotinamide analogue: Investigations into in silico analysis, antiproliferative effects, selectivity, VEGFR-2 inhibition, apoptosis induction, and migration suppression, Pathol. Res. Pract., 252 (2023) 154924.
13. Ç. Karabacak Atay, Ö. Dilek, T. Tilki, B. Dede, A novel imidazole-based azo molecule: synthesis, characterization, quantum chemical calculations, molecular docking, molecular dynamics simulations and ADMET properties, J. Mol. Model, 29 (2023) 226.
14. Ö. Dilek, B. Dede, Ç. Karabacak Atay, T. Tilki, Promising agent for the efficient extraction of Co(II) ions from aqueous medium and its metal complexes: Synthesis, theoretical calculations and solvent extraction, Polyhedron, 250 (2024) 116843.
15. Frisch, M. J., G. W., Trucks, H. B., Schlegel, G. E., Scuseria, M. A., Robb, J. R., Cheeseman, G., Scalmani, V., Barone, G. A., Petersson, H., Nakatsuji, X., Li, M., Caricato, A., Marenich, J., Bloino, B. G., Janesko, R., Gomperts, B., Mennucci, H. P., Hratchian, J. V., Ortiz, A. F I., D. J. F. 2016. Gaussian 09, Revision E.01. Gaussian, Inc.
16. O. Trott, A.J. Olson, AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem., 31 (2010) 455–461.
17. H.M. Berman, The Protein Data Bank, Nucleic Acids Res., 28 (2000) 235–242.
18. B. Webb, A. Sali, Comparative Protein Structure Modeling Using MODELLER, Curr. Protoc. Bioinformatics, 54 (2016) 5.6.1-5.6.37.
19. BIOVIA (2021) Discovery Studio Visualizer, version 21.1.0.20298. Dassault Systèmes, San Diego, CA.
20. E.F. Pettersen, T.D. Goddard, C.C. Huang, G.S. Couch, D.M. Greenblatt, E.C. Meng, T.E. Ferrin, UCSF Chimera—A visualization system for exploratory research and analysis, J. Comput. Chem., 25 (2004) 1605–1612.
21. E. Krieger, G. Vriend, YASARA View—molecular graphics for all devices—from smartphones to workstations, Bioinformatics, 30 (2014) 2981–2982.
22. E. Krieger, R.L. Dunbrack, R.W.W. Hooft, B. Krieger, Assignment of Protonation States in Proteins and Ligands: Combining pKa Prediction with Hydrogen Bonding Network Optimization, in: 2012: pp. 405–421.
23. E. Krieger, J.E. Nielsen, C.A.E.M. Spronk, G. Vriend, Fast empirical pKa prediction by Ewald summation, J. Mol. Graph. Model, 25 (2006) 481–486.
24. J.A. Maier, C. Martinez, K. Kasavajhala, L. Wickstrom, K.E. Hauser, C. Simmerling, ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB, J. Chem. Theory Comput., 11 (2015) 3696–3713.
25. J. Wang, R.M. Wolf, J.W. Caldwell, P.A. Kollman, D.A. Case, Development and testing of a general amber force field, J. Comput. Chem., 25 (2004) 1157–1174.
26. A. Jakalian, D.B. Jack, C.I. Bayly, Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: II. Parameterization and validation, J. Comput. Chem., 23 (2002) 1623–1641.
27. V. Hornak, R. Abel, A. Okur, B. Strockbine, A. Roitberg, C. Simmerling, Comparison of multiple Amber force fields and development of improved protein backbone parameters, Proteins: Structure, Function, and Bioinformatics 65 (2006) 712–725.
28. U. Essmann, L. Perera, M.L. Berkowitz, T. Darden, H. Lee, L.G. Pedersen, A smooth particle mesh Ewald method, J. Chem. Phys., 103 (1995) 8577–8593.
29. E. Krieger, G. Vriend, New ways to boost molecular dynamics simulations, J. Comput. Chem., 36 (2015) 996–1007.